Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04715386 · ClinicalTrials.gov registry record
Feasibility in the Prophylaxis of Radiation Dermatitis Severity
A clinical trial, sponsored by Mayo Clinic.
- Terminated
- Registry status
- 14
- Enrollment target
NCT04715386: Clinical Trial study, sponsored by Mayo Clinic.
NCT04715386 is a clinical trial that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 14 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04715386 was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- 14 participants
- Enrollment target
Study Summary
To compare radiation dermatitis severity in irradiated skin protected by an agent verses uncovered skin based on photographs and track patient reported outcomes with use of the agent.
Interventions
- DRUG StrataXRT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2020-06-22 |
| Est. Completion | 2024-01-30 |
Why NCT04715386 stopped before completion
NCT04715386 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 14 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which StrataXRT is the first listed.
NCT04715386 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04715386 about?
NCT04715386 is a clinical study titled "Feasibility in the Prophylaxis of Radiation Dermatitis Severity". To compare radiation dermatitis severity in irradiated skin protected by an agent verses uncovered skin based on photographs and track patient reported outcomes with use of the agent.
What is the current status of trial NCT04715386?
This trial is currently terminated. The enrollment target is 14 participants. The study started on 2020-06-22. Estimated completion is 2024-01-30.
What interventions are being tested in trial NCT04715386?
The interventions under investigation include: StrataXRT (DRUG).
Who is sponsoring clinical trial NCT04715386?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy